Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Cannabidiol Safety In Question At US FDA? Exploding Market Suggests Not So Much

Mar 15 2020

• By Malcolm Spicer

US map-cannibis-plants

Related Content

FDA Warns 15 CBD Product Marketers For Violations, Cautions Consumers: CBD May Harm You

Nov 27 2019

Confidentiality For Proprietary Information Drives FDA Plan To Generate More CBD Safety Data

Mar 06 2020

Digital Citizens Study Finds Many CBD Products Are Placebos And Most Are Inaccurately Labeled

Mar 15 2020

Future Of CBD In Supplements: NDI Notification Looms As Regulatory Path

Dec 03 2019

Additional Topics

United States Dietary Supplements FDA Enforcement Advertising, Marketing & Sales Business Strategies Commercial Compliance Distribution E-Commerce Ingredients Manufacturing Policy Regulation Safety Consumer

More from Regulation

More from Policy & Regulation

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window